>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

ADAP +8.5%, ANY +7.1%, GNRT +6.6%, KOPN +4.8%, KRO +2%, DVAX +0.9%

M&A news:

.MBLY +31.1% (confirms it has agreed to be acquired by Intel (INTC) for $63.54/share in cash, or ~ $15.3 bln (shares halted))
AMFW +14.4% (to be acquired by John Wood Group (WDGJF) valued at GBP2.23 bln)

Select metals/mining stocks trading higher:

RIO +3.6%, MT +3.3%, AG +3.1%, CLF +3%, VALE +3%, BBL +2.5%, X+2.4%, FCX +2.2%, AUY +1.9%
BHP +1.9%, AKS +1.8%, AA +1.4%, NEM +1.2%, GG +1.2%, PAAS +1.1%,GDX +0.7%

Other news:

HTBX +44.4% (achieves the efficacy endpoint for its Phase 1b trial evaluating HS-110 in combination with Bristol-Myers Squibb's (BMY) nivolumab)
SDRL +9.7% (reports settlement in West Mira arbitration; to receive $170 mln as settlement in dispute)
OCRX +7.9% (continued weakness post Friday's earnings)
FATE +7.3% (FDA has cleared an investigational new drug application for FATE-NK100)
IBN +3.7% (following India elections; PM Modi re-elected)
AMD +3.5% (to be added to S&P MidCap 400)
HEBT +3.2% (to acquire a majority equity interest in Shanghai Xinxiao)
BX +2.5% (NCR Corp enters into an agreement with Blackstone (BX), under which Blackstone is granted an early release from its lockup to sell a portion of its holdings to allow it to recoup its investment;)
INCY +1.8% (files Form 424B7 prospectus for 34,033,451 shares of common stock held by selling stockholder Baker Bros)
HSBC +1.3% (appoints Mark Tucker as Group Chairman to succeed Douglas Flint Sep 1)
ZYNE +1% (completes enrollment for ZYN002 in two Phase 2 clinical trials for epilepsy and osteoarthritis)

Analyst comments: